Cilcare is a French biotech SME that focuses on the early detection and treatment of hearing disorders. Learn about its journey to the Japanese market.

NovAlix is a drug discovery-focused Contract Research Organization (CRO) that was founded in Strasbourg, France, in 2002. Learn about its journey to the Japanese market.

ENOGIA is a French SME specializing in the design and manufacture of micro-turbomachinery. Read our latest Success Story to gain valuable insights into the challenges they encountered, the strategies they employed, and their advice for other SMEs aspiring to establish a presence in the land of the Rising Sun!

XLAB is an IT company founded in 2001 at the Ljubljana Technology Park in Slovenia. XLAB has since expanded into a global enterprise. It actively contributes to the European research sphere and provides services to users in more than 100 countries. 

In the past decade, the Centre supported a total of 128 companies’ representatives on their road to access the Japanese market. Read abstracts of 2 success stories by former participants. The whole interviews are available on our website.

Do you want to know more about the GRFJ training impact on former participants? Have a look at abstracts from 3 success stories from Sweden, Estonia and Spain.

The EU-Japan Centre for Industrial Cooperation recently published a list of 25 projects between EU and Japanese companies taking place in Southeast Asia. Through these case studies, the EU-Japan Centre aims to encourage EU and Japanese companies to consider collaboration in Southeast Asia.

Abbeal is a French start-up specializing in web and mobile development consultancy.

TreeFrog Therapeutics (https://treefrog.fr/) is a French biotechnology company specialized in cell therapy. In April 2022, Treefrog announced the opening of a lab in Kobe, Japan, with the aim of establishing strategic alliances with key academic and industrial players in the field of regenerative medicine. Discover the company’s reception in Japan, their encountered challenges, and recommendations to other EU SMEs by reading our Case Study.

TreeFrog Therapeutics is a French biotechnology company specialized in cell therapy. In April 2022, it announced the opening of a lab in Kobe, Japan, with the aim of establishing strategic alliances with key academic and industrial players in the field of regenerative medicine.